Works by Nakamoto, Shingo


Results: 71
    1
    2
    3

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    4

    Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection.

    Published in:
    Hepatology Research, 2024, v. 54, n. 8, p. 1, doi. 10.1111/hepr.14062
    By:
    • Kanda, Tatsuo;
    • Li, Tian‐Cheng;
    • Takahashi, Masaharu;
    • Nagashima, Shigeo;
    • Primadharsini, Putu Prathiwi;
    • Kunita, Satoshi;
    • Sasaki‐Tanaka, Reina;
    • Inoue, Jun;
    • Tsuchiya, Atsunori;
    • Nakamoto, Shingo;
    • Abe, Ryuzo;
    • Fujiwara, Keiichi;
    • Yokosuka, Osamu;
    • Suzuki, Ryosuke;
    • Ishii, Koji;
    • Yotsuyanagi, Hiroshi;
    • Okamoto, Hiroaki;
    • Totsuka, Mai;
    • Honda, Masayuki;
    • Arima, Shuhei
    Publication type:
    Article
    5

    Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan.

    Published in:
    Hepatology Research, 2024, v. 54, n. 1, p. 4, doi. 10.1111/hepr.13983
    By:
    • Kanda, Tatsuo;
    • Sasaki‐Tanaka, Reina;
    • Ishii, Koji;
    • Suzuki, Ryosuke;
    • Inoue, Jun;
    • Tsuchiya, Atsunori;
    • Nakamoto, Shingo;
    • Abe, Ryuzo;
    • Fujiwara, Keiichi;
    • Yokosuka, Osamu;
    • Li, Tian‐Cheng;
    • Kunita, Satoshi;
    • Yotsuyanagi, Hiroshi;
    • Okamoto, Hiroaki;
    • Totsuka, Mai;
    • Honda, Masayuki;
    • Arima, Shuhei;
    • Masuzaki, Ryota;
    • Matsumoto, Naoki;
    • Ogawa, Masahiro
    Publication type:
    Article
    6

    Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
    By:
    • Fujita, Naoto;
    • Kanogawa, Naoya;
    • Makishima, Hirokazu;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Shiko, Yuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Wakatsuki, Masaru;
    • Itobayashi, Ei;
    • Obu, Masamichi;
    • Koma, Yoshihiro;
    • Azemoto, Ryosaku
    Publication type:
    Article
    7
    8
    9

    EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00889-0
    By:
    • Kusakabe, Yuko;
    • Chiba, Tetsuhiro;
    • Oshima, Motohiko;
    • Koide, Shuhei;
    • Rizq, Ola;
    • Aoyama, Kazumasa;
    • Ao, Junjie;
    • Kaneko, Tatsuya;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Maeda, Takahiro;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Yasui, Shin
    Publication type:
    Article
    10
    11
    12
    13

    Switching to systemic therapy after locoregional treatment failure: Definition and best timing.

    Published in:
    Clinical & Molecular Hepatology, 2020, v. 26, n. 2, p. 155, doi. 10.3350/cmh.2019.0021n
    By:
    • Sadahisa Ogasawara;
    • Yoshihiko Ooka;
    • Keisuke Koroki;
    • Susumu Maruta;
    • Hiroaki Kanzaki;
    • Kengo Kanayama;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Eiichiro Suzuki;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Tetsuhiro Chiba;
    • Makoto Arai;
    • Jun Kato;
    • Naoya Kato
    Publication type:
    Article
    14
    15
    16
    17

    The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84117-9
    By:
    • Kanzaki, Hiroaki;
    • Chiba, Tetsuhiro;
    • Ao, Junjie;
    • Koroki, Keisuke;
    • Kanayama, Kengo;
    • Maruta, Susumu;
    • Maeda, Takahiro;
    • Kusakabe, Yuko;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Muroyama, Ryosuke;
    • Nakamoto, Shingo
    Publication type:
    Article
    18
    19
    20
    21

    Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 12015, doi. 10.3390/ijms231912015
    By:
    • Ma, Yaojia;
    • Nakamoto, Shingo;
    • Ao, Junjie;
    • Qiang, Na;
    • Kogure, Tadayoshi;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakagawa, Ryo;
    • Ogasawara, Sadahisa;
    • Muroyama, Ryosuke
    Publication type:
    Article
    22
    23
    24

    Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors.

    Published in:
    International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 906, doi. 10.3390/ijms18050906
    By:
    • Tatsuo Kanda;
    • Shin Yasui;
    • Masato Nakamura;
    • Eiichiro Suzuki;
    • Makoto Arai;
    • Yoshihiko Ooka;
    • Sadahisa Ogasawara;
    • Tetsuhiro Chiba;
    • Tomoko Saito;
    • Yuki Haga;
    • Koji Takahashi;
    • Reina Sasaki;
    • Shuang Wu;
    • Shingo Nakamoto;
    • Akinobu Tawada;
    • Hitoshi Maruyama;
    • Fumio Imazeki;
    • Naoya Kato;
    • Osamu Yokosuka
    Publication type:
    Article
    25
    26
    27

    Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment.

    Published in:
    International Journal of Molecular Sciences, 2014, v. 15, n. 11, p. 21455, doi. 10.3390/ijms151121455
    By:
    • Shingo Nakamoto;
    • Tatsuo Kanda;
    • Chiaki Nakaseko;
    • Emiko Sakaida;
    • Chikako Ohwada;
    • Masahiro Takeuchi;
    • Yusuke Takeda;
    • Naoya Mimura;
    • Tohru Iseki;
    • Shuang Wu;
    • Makoto Arai;
    • Fumio Imazeki;
    • Kengo Saito;
    • Shirasawa, Hiroshi;
    • Osamu Yokosuka
    Publication type:
    Article
    28
    29
    30

    Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology, 2024, v. 59, n. 6, p. 515, doi. 10.1007/s00535-024-02097-9
    By:
    • Fujiwara, Kisako;
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ogawa, Keita;
    • Ishino, Takamasa;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Tsuchiya, Satoshi;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Koizumi, Jun
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38

    Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 2, p. 332, doi. 10.1007/s10637-017-0507-3
    By:
    • Sadahisa Ogasawara;
    • Tetsuhiro Chiba;
    • Yoshihiko Ooka;
    • Eiichiro Suzuki;
    • Takahiro Maeda;
    • Masayuki Yokoyama;
    • Toru Wakamatsu;
    • Masanori Inoue;
    • Tomoko Saito;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Shingo Nakamoto;
    • Shin Yasui;
    • Akinobu Tawada;
    • Makoto Arai;
    • Tatsuo Kanda;
    • Hitoshi Maruyama;
    • Osamu Yokosuka;
    • Naoya Kato
    Publication type:
    Article
    39
    40
    41

    The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25350-8
    By:
    • Kondo, Takayuki;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Ogasawara, Sadahisa;
    • Suzuki, Eiichiro;
    • Ooka, Yoshihiko;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Arai, Makoto
    Publication type:
    Article
    42
    43
    44

    Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.

    Published in:
    PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261619
    By:
    • Kondo, Takayuki;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Arai, Makoto;
    • Kato, Jun;
    • Kuboki, Satoshi;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    45

    Changes in therapeutic options for hepatocellular carcinoma in Asia.

    Published in:
    Liver International, 2022, v. 42, n. 9, p. 2055, doi. 10.1111/liv.15101
    By:
    • Sadahisa Ogasawara;
    • Keisuke Koroki;
    • Hiroaki Kanzaki;
    • Kazufumi Kobayashi;
    • Soichiro Kiyono;
    • Masato Nakamura;
    • Naoya Kanogawa;
    • Tomoko Saito;
    • Takayuki Kondo;
    • Ryo Nakagawa;
    • Shingo Nakamoto;
    • Ryosuke Muroyama;
    • Tetsuhiro Chiba;
    • Naoya Kato
    Publication type:
    Article
    46

    Changes in therapeutic options for hepatocellular carcinoma in Asia.

    Published in:
    Liver International, 2022, v. 42, n. 8, p. 2055, doi. 10.1111/liv.15101
    By:
    • Ogasawara, Sadahisa;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Saito, Tomoko;
    • Kondo, Takayuki;
    • Nakagawa, Ryo;
    • Nakamoto, Shingo;
    • Muroyama, Ryosuke;
    • Chiba, Tetsuhiro;
    • Kato, Naoya
    Publication type:
    Article
    47

    Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer.

    Published in:
    Oncology Letters, 2020, v. 20, n. 3, p. 2161, doi. 10.3892/ol.2020.11757
    By:
    • Imai, Yushi;
    • Chiba, Tetsuhiro;
    • Kondo, Takayuki;
    • Kanzaki, Hiroaki;
    • Kanayama, Kengo;
    • Ao, Junjie;
    • Kojima, Ryuta;
    • Kusakabe, Yuko;
    • Nakamura, Masato;
    • Saito, Tomoko;
    • Nakagawa, Ryo;
    • Suzuki, Eiichiro;
    • Nakamoto, Shingo;
    • Muroyama, Ryosuke;
    • Tawada, Akinobu;
    • Matsumura, Tomoaki;
    • Nakagawa, Tomoo;
    • Kato, Jun;
    • Kotani, Ai;
    • Matsubara, Hisahiro
    Publication type:
    Article
    48
    49

    Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 3, p. 286, doi. 10.1159/000542577
    By:
    • Koroki, Keisuke;
    • Ogasawara, Sadahisa;
    • Izai, Ryo;
    • Yonemoto, Takuya;
    • Akatsuka, Teppei;
    • Miwa, Chihiro;
    • Yumita, Sae;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nakada, Shinichiro;
    • Sakai, Nozomu;
    • Yokoyama, Masayuki;
    • Ohtsuka, Masayuki;
    • Kato, Naoya
    Publication type:
    Article
    50

    Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.

    Published in:
    Liver Cancer (2235-1795), 2025, v. 14, n. 1, p. 8, doi. 10.1159/000539380
    By:
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Kobayashi, Kazufumi;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Obu, Masamichi;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Yumita, Sae;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Nagashima, Kengo;
    • Itobayashi, Ei
    Publication type:
    Article